Zarzio

Zarzio (Filgrastim) is a prescription injectable used to stimulate white blood cell production in patients undergoing chemotherapy or bone marrow transplant. It belongs to the colony-stimulating factor class and is administered via injection. Always consult a healthcare provider before use.

Zarzio is commonly used to reduce the risk of infection in people with certain types of cancer who are receiving chemotherapy that lowers white blood cells. It may also aid recovery after bone marrow transplant and in patients with severe chronic neutropenia. This medication helps the body make more neutrophils, a type of white blood cell. It does not treat infections directly but supports the immune system during treatment.

After administration, Zarzio works by prompting the bone marrow to release more white blood cells into the bloodstream. Patients may notice improved energy levels as their immune function stabilizes. Some users report mild injection-site reactions like redness or swelling. These effects are typically temporary and vary by individual.

Store Zarzio in the refrigerator and protect it from light. Do not freeze or shake the vial or prefilled syringe. Always inspect the liquid for particles or discoloration before use. Keep out of reach of children and pets. Dispose of used needles and syringes in a sharps container as directed.

Zarzio may interact with other drugs that affect bone marrow function, such as chemotherapy or immunosuppressants. Avoid live vaccines during treatment unless approved by a doctor. Some medications, including lithium, may enhance its effects. Always inform your healthcare provider about all medications and supplements you are taking.